increasing pressure for drug companies to register ALL their studies
October 2004
There's increasing pressure for drug companies to register ALL their studies...and not just publish the ones with good outcomes.
This is part of the backlash over drug companies withholding data about suicide and antidepressants.
Top medical journals will require drug companies to register studies before they start...if they want studies to be published when they're finished.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote